Research programme: magainin peptides - Genaera
Alternative Names: Magainin peptides research programme - GenaeraLatest Information Update: 18 May 2006
At a glance
- Originator Genaera Corporation
- Class Peptides
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bacterial infections; Cancer; Pregnancy
Most Recent Events
- 18 May 2006 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 18 May 2006 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 18 May 2006 Discontinued - Preclinical for Pregnancy (Prevention) in India (Vaginal)